Clinical Trials Browser

Muscle-Invasive Bladder Carcinoma × Cisplatin × Clear all

NCT05203913 2024-10-04

CNN-BC

Phase 2 Recruiting

Muscle-Invasive Bladder Carcinoma

NCT04909775 2021-06-02

Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

Phase 2 Unknown

Muscle-Invasive Bladder Carcinoma